Efficacy and Safety of Covid-19 Vaccines in Pediatric Patients

CSACI WEBINAR

Efficacy and Safety of Covid-19 Vaccines in Pediatric Patients

Join us on April 13th at 7:30 PM EST to talk about the efficacy and safety of Covid19 vaccines in pediatric patients and approach to adverse reactions in this population.  

Moderated by:  Dr. Victoria Cook (Victoria, BC)

Panelists:  Dr. Jim Kellner (Calgary, AB), Dr. Anne Pham-Huy (Ottawa, ON) & Dr. Julia Upton (Toronto, ON)

Learning Objectives

By the end of the session, learners will be able to: 

1. Outline available evidence for use COVID19 vaccination in the pediatric population, including an update on vaccination studies in children <5 years of age. 
2. Describe common and uncommon adverse reactions to COVID19 vaccination in the pediatric population, including anaphylaxis.
3. Discuss approach to PEG allergy and anaphylaxis evaluation to COVID19 vaccines in the pediatric population, in particular those with documented allergy to PEG-Asparaginase

“This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Society of Allergy and Clinical Immunology.”

For more information, please visit:  https://www.csaci.ca/pediatric_covid19_webinar/